Literature DB >> 32158094

Key Determinants of Phenotypic Heterogeneity of Hb E/β Thalassemia: A Comparative Study from Eastern India.

Siddhesh Arun Kalantri1, Rudra Ray1, Soumita Choudhuri1, Swarnalata Roy1, Maitreyee Bhattacharyya1.   

Abstract

HbE Beta thalassemia is phenotypically very diverse disease. We aim to study role of various genetic factors in determining severity of this disease. 243 diagnosed cases of HbE Beta thalassemia were included in this study. Patients were divided in two arms-transfusion dependent and non-transfusion dependent arms. Various factors (percentage of haemoglobin F, hemoglobin E, type of Beta mutation, Xmn1 polymorphism, alpha deletion, HPFH mutation) were evaluated in these patients. Xmn1 polymorphism (homozygous and heterozygous), presence of HPFH mutation and alpha deletion were more prevalent in NTDT arm versus TDT arm (p value < 0.001). Higher prevelance of severe beta mutation IVS 1-5 (G → C) mutation {64(61.54%) vs 38(27.34); p value < 0.001} was found in TDT arm when above factors were excluded from analysis. Higher mean haemoglobin F and mean Hemoglobin E percentage was associated with NTDT arm (p value < 0.001). Various factors (hemoglobin F and E percentage, Xmn1 polymorphism, HPFH mutation, alpha deletion and IVS 1-5 Beta mutation) were identified to affect severity of this cohort. © Indian Society of Hematology and Blood Transfusion 2019.

Entities:  

Keywords:  Genotype; HbE Beta thalassemia; NTDT; Phenotype; TDT

Year:  2019        PMID: 32158094      PMCID: PMC7042442          DOI: 10.1007/s12288-019-01176-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  12 in total

1.  Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions.

Authors:  Y T Liu; J M Old; K Miles; C A Fisher; D J Weatherall; J B Clegg
Journal:  Br J Haematol       Date:  2000-02       Impact factor: 6.998

2.  Haemoglobin E beta thalassaemia in Sri Lanka.

Authors:  A Premawardhena; C A Fisher; N F Olivieri; S de Silva; M Arambepola; W Perera; A O'Donnell; T E A Peto; V Viprakasit; L Merson; G Muraca; D J Weatherall
Journal:  Lancet       Date:  2005 Oct 22-28       Impact factor: 79.321

3.  Effect of alpha-gene numbers on phenotype of HbE/beta thalassemia patients.

Authors:  Vineeta Sharma; Renu Saxena
Journal:  Ann Hematol       Date:  2009-03-12       Impact factor: 3.673

Review 4.  Genetic factors affecting clinical severity in beta-thalassemia syndromes.

Authors:  P Winichagoon; S Fucharoen; P Chen; P Wasi
Journal:  J Pediatr Hematol Oncol       Date:  2000 Nov-Dec       Impact factor: 1.289

5.  Severity differences in beta-thalassaemia/haemoglobin E syndromes: implication of genetic factors.

Authors:  P Winichagoon; V Thonglairoam; S Fucharoen; P Wilairat; Y Fukumaki; P Wasi
Journal:  Br J Haematol       Date:  1993-04       Impact factor: 6.998

Review 6.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study.

Authors:  D Mohanty; R B Colah; A C Gorakshakar; R Z Patel; D C Master; J Mahanta; S K Sharma; U Chaudhari; M Ghosh; S Das; R P Britt; S Singh; C Ross; L Jagannathan; R Kaul; D K Shukla; V Muthuswamy
Journal:  J Community Genet       Date:  2012-10-21

8.  Anemia and hemoglobinopathies in tribal population of Eastern and North-eastern India.

Authors:  Madhusnata De; Ajanta Halder; Sandeep Podder; Rinini Sen; Shila Chakrabarty; Bani Sengupta; Tulika Chakraborty; Urmisha Das; Geeta Talukder
Journal:  Hematology       Date:  2006-10       Impact factor: 2.269

Review 9.  Hb E/beta-thalassaemia: a common & clinically diverse disorder.

Authors:  Nancy F Olivieri; Zahra Pakbaz; Elliott Vichinsky
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

10.  Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh.

Authors:  Sanjana Bhagat; Pradeep Kumar Patra; Amar Singh Thakur
Journal:  Int J Biomed Sci       Date:  2012-03
View more
  1 in total

Review 1.  Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β-Thalassemia.

Authors:  Nur Atikah Zakaria; Md Asiful Islam; Wan Zaidah Abdullah; Rosnah Bahar; Abdul Aziz Mohamed Yusoff; Ridhwan Abdul Wahab; Shaharum Shamsuddin; Muhammad Farid Johan
Journal:  Biomolecules       Date:  2021-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.